Danoprevir (ITMN-191)

Danoprevir (ITMN-191)CAS号: 850876-88-9分子式: C35H46FN5O9S分子量: 731.83描述纯度储存/保存方法别名可溶性/溶解性靶点In vitro(体外研究)In vivo(体内研究)参考文献

产品描述
描述

Danoprevir (ITMN-191)是一种肽类抑制剂,作用于丙型肝炎病毒(HCV)的NS3/4A蛋白酶,IC50为0.2-3.5 nM,抑制HCV 1A/1B/4/5/6基因型比抑制2B/3A基因型效果高10倍左右。0.29 nM Danoprevir抑制NS3/4A 蛋白酶, 而10 μM Danoprevir 却不能抑制一组79种蛋白酶,离子通道,转运蛋白,及细胞表面受体。Danoprevir与 NS3/4A第一次结合能维持5小时以上,且保持抑制作用状态。Danoprevir (45 nM) 消除病人肝细胞衍生的Huh7细胞衍生的HCV基因型1b复制子,EC50为1.8 nM。

纯度
98%
储存/保存方法
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
基本信息
别名
ITMN-191;R7227;RO5190591;RG72277;丹诺普韦
可溶性/溶解性
Ethanol :133 mg/mL (181.7 mM)

DMSO :133 mg/mL (181.7 mM)

生物活性
靶点
HCV NS3/4A protease
In vitro(体外研究)
Danoprevir (0.29 nM) inhibits the reference genotype 1 NS3/4A protease half-maximally, but a high dose of Danoprevir (10 μM) shows no appreciably inhibition in a panel of 79 proteases, ion channels, transporters, and cell surface receptors. Danoprevir remains bound to and inhibits NS3/4A for more than 5 hours after its initial association. Danoprevir (45 nM) eliminates a patient-derived HCV genotype 1b replicon from hepatocyte-derived Huh7 cells with an EC50 of 1.8 nM. In HCV subgenomic replicon cell lines containing the individual mutations, V36M, R109K, and V170A substitutions confer little or no resistance to Danoprevir, but the R155K substitution confers a high level (62-fold increase) of resistance to Danoprevir. In Huh7.5 cells transfected with chimeric recombinant virus, Danoprevir shows antiviral inhibition effects against HCV genotypes 1, 4 and 6 with IC50 of 2-3 nM, which are >100-fold lower than genotypes 2/3/5 (280-750 nM).
In vivo(体内研究)
Danoprevir (30 mg/kg) administered to rats or monkeys shows that its concentrations in liver 12 hours after dosing exceed the Danoprevir concentration required to eliminate replicon RNA from cells.
参考文献
参考文献
Characterization of HCV quasispecies dynamics upon short term dual-therapy with the HCV NS5B nucleoside polymerase inhibitor mericitabine and the NS3/4 protease inhibitor danoprevir.
Le Pogamet al. Antimicrob Agents Chemother. 2012 Aug 6. PMID: 뢜અ 뢥અᙘ௛鹿椖痛ᙄ௛ኸ叫ۇ痮￾￿蘿䙔痬ﮥz娱痭ᡸ׶졡蘿滑뛿ନࠄ￿￿ﯴଭ뜓ନﭵz�ଭ鶔๟숲W卵ࠄ쉇WValu落鸤๟煮靖쌀W煮充 﫤眥ŞԐั縷Ş廤眸塞욭塞뛥@﷩ 歷䗧@磻蔲@ᘸ௛臭隸
뭥@列뮂@뮊@臭㌸Š眥؀ั眥榄๟榐๟嵭ଧ鳘๟ᔇଧ榐๟倫廼ଧ榄๟﫤鳤๟嵥ଧ鶠๟崿ଧᘰଧ懲鶠๟嵭ଧᙐଧᙧଧ鶠๟﨔樍痯鸤๟懲懲痭཰́ 驣B縉鸤๟褐靰B煮﫤ﭬz充充韈B褐薰௬計ͅ煮zﰈzﯰ﫤ﭬz婢zﰈ戴zﰈﰤﬠzﰈ཰́薰௬횐z 顴๟

分子结构图

Danoprevir (ITMN-191)